|Last Price||Today's Change||52-Week Range||Trading Volume|
|56.26||0.21 (+0.37%)||44.60 - 58.14||9.6 million (Below Avg)|
Market data as of 4:01PM 04/16/14. Quotes are delayed by at least 15 min.
FDA Approves Merck’s GRASTEK® (Timothy Grass Pollen Allergen Extract) Sublingual Tablet as Immunotherapy to Treat Grass Pollen-Induced Allergic Rhinitis with or without Conjunctivitis in Children and Adults
04/14/2014 5:59 PM ET